logo
Select company
Select metric
$ 51.74MNet Cash Flow - Financing
VS
Market
22
Sector
21
Industry
27
History
38
$ 0.23Close
$ 0.19 - $ 0.44 52-Week Range
Ticker Information

Ticker

NWBO

Company Name

NORTHWEST BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

NORTHWEST BIOTHERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NWBO - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 51.74M
3/31/2025$ 56.43M
12/31/2024$ 56.78M
9/30/2024$ 55.26M
6/30/2024$ 60.76M
3/31/2024$ 52.26M
12/31/2023$ 52.76M
9/30/2023$ 49.69M
6/30/2023$ 48.86M
3/31/2023$ 50.63M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NORTHWEST BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 42.01M.
  • Over the past 5 years, NORTHWEST BIOTHERAPEUTICS INC's average CF - Financing has been $ 50.36M.
  • The median CF - Financing for NORTHWEST BIOTHERAPEUTICS INC during this period was $ 51.19M
  • NORTHWEST BIOTHERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 60.76M.
  • The lowest CF - Financing recorded by NORTHWEST BIOTHERAPEUTICS INC in the same timeframe $ 40.28M

NORTHWEST BIOTHERAPEUTICS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
RNAC : CARTESIAN THERAPEUTICS INC $ 117.31MINBX : INHIBRX BIOSCIENCES INC $ 99.84MHUMA : HUMACYTE INC $ 100.76MABEO : ABEONA THERAPEUTICS INC $ 22.28MMREO : MEREO BIOPHARMA GROUP PLC $ -346KSEPN : SEPTERNA INC $ 303.23MCRDF : CARDIFF ONCOLOGY INC $ 51.62MCATX : PERSPECTIVE THERAPEUTICS INC $ 11.08MBTAI : BIOXCEL THERAPEUTICS INC $ 18.07MADVM : ADVERUM BIOTECHNOLOGIES INC $ 359K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

NWBO - Net Cash Flow - Financing, Last 5 years

$ 40.28M

Minimum

Sep 30, 2021

$ 60.76M

Maximum

Jun 30, 2024

$ 50.36M

Average

$ 51.19M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.74M with a standard deviation of $ 119.11M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -367.1M
max$ 366M
average$ -6.74M
median$ 314K
std$ 119.11M